Literature DB >> 2096603

Comparative study of lyophilized human dura mater and lyophilized bovine pericardium as dural substitutes in neurosurgery.

A Laun1, J C Tonn, C Jerusalem.   

Abstract

In a prospective, controlled randomized study either lyophilized bovine pericardium or lyophilized human dura mater have been used as a patch for the closure of the dura in 102 patients. The aim of this investigation was to compare both materials in terms of immunogenic response of the patients. The rate of post-operative complications was comparably low in both groups (wound infection in 1/51 patients each). In regard of workability, thickness of the material and flexibility the pericardium patches were judged to be by far superior. Neither signs of a cellular nor of an intesified humoral response could be detected in patients who received the pericardium implants. Thus, lyophilized bovine pericardium seems to be a superior alternative for the surgical repair of dural defects.

Entities:  

Mesh:

Year:  1990        PMID: 2096603     DOI: 10.1007/bf01402607

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  Clinical use of freeze-dried human dura mater.

Authors:  J B CAMPBELL; C A BASSETT; J W ROBERTSON
Journal:  J Neurosurg       Date:  1958-03       Impact factor: 5.115

2.  Neurosurgical use of human dura mater sterilized by gamma rays and stored in alcohol: long-term results.

Authors:  G Cantore; B Guidetti; R Delfini
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

3.  Patch grafting the renal pelvis and ureteropelvic junction. A comparative study in pigs using lyophilized dura mater and free peritoneum.

Authors:  P L Royce; P E Zimmern; J B deKernion
Journal:  Urol Res       Date:  1988

4.  Clinical experience with glutaraldehyde-preserved heterologous pericardium for the closure of the pericardium after open heart surgery.

Authors:  J I Gallo; E Artiñano; C M Duran
Journal:  Thorac Cardiovasc Surg       Date:  1982-10       Impact factor: 1.827

5.  Reproducible replacement of elongated or ruptured mitral valve chordae.

Authors:  R W Frater; S Gabbay; D Shore; S Factor; J Strom
Journal:  Ann Thorac Surg       Date:  1983-01       Impact factor: 4.330

6.  The use of adhesive and lyophilized dura in the treatment of cerebrospinal rhinorrhea. Technical note.

Authors:  R A Lehman; G J Hayes; A N Martins
Journal:  J Neurosurg       Date:  1967-01       Impact factor: 5.115

7.  Early experience with the ionescu-shiley pericardial xenograft valve. Accelerated calcification in children.

Authors:  W E Walker; J M Duncan; O H Frazier; J J Livesay; D A Ott; G J Reul; D A Cooley
Journal:  J Thorac Cardiovasc Surg       Date:  1983-10       Impact factor: 5.209

8.  Replacement of obstructed extracardiac conduits with autogenous tissue reconstructions.

Authors:  G K Danielson; T P Downing; H V Schaff; F J Puga; R M DiDonato; D G Ritter
Journal:  J Thorac Cardiovasc Surg       Date:  1987-04       Impact factor: 5.209

9.  Reconstruction of the pericardial sac with glutaraldehyde-preserved bovine pericardium.

Authors:  V S Yakirevich; S A Abdulali; C R Abbott; M I Ionescu
Journal:  Tex Heart Inst J       Date:  1984-09

10.  Bovine pericardium for correction of congenital heart defects.

Authors:  F A Crawford; R M Sade; F Spinale
Journal:  Ann Thorac Surg       Date:  1986-06       Impact factor: 4.330

View more
  12 in total

1.  Increase in the lumen of the femoral artery in dogs with an arteriotomy encircled by glutaraldehyde-tanned calf pericardium.

Authors:  J Sotelo; R Perez; G Ordoñez
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

2.  Bladder repair following iatrogenic cystotomy in irradiated small capacity bladders.

Authors:  J Y Chee; P Durai; F M Wu; H Y Tiong
Journal:  Singapore Med J       Date:  2015-03       Impact factor: 1.858

3.  Experimental evaluation of new chitin-chitosan graft for duraplasty.

Authors:  M Pogorielov; A Kravtsova; G C Reilly; V Deineka; G Tetteh; O Kalinkevich; O Pogorielova; R Moskalenko; G Tkach
Journal:  J Mater Sci Mater Med       Date:  2017-01-21       Impact factor: 3.896

4.  Suturing-Free Artificial Dura with Dacron Heart Patch in Decompressive Craniectomy and Cranioplasty.

Authors:  Fei Wang; Yan Xue; Si-Shun Zhao; Ting-Jian Yang; Hao-Qing Song; Hong Liu
Journal:  Indian J Surg       Date:  2014-06-08       Impact factor: 0.656

5.  Posterior fossa duraplasty in children: remarks on surgery and clinical and CT follow-up.

Authors:  J Parízek; M Sercl; A Michl; P Mĕricka; S Nĕmecek; J Nĕmecková; J Jakubec
Journal:  Childs Nerv Syst       Date:  1994-09       Impact factor: 1.475

6.  Experience with management of anterior abdominal wall defects using bovine pericard.

Authors:  Cornelia van Tuil; Amulya K Saxena; Günter H Willital
Journal:  Hernia       Date:  2006-02-18       Impact factor: 4.739

Review 7.  Risk of meningitis after posterior fossa decompression with duraplasty using different graft types in patients with Chiari malformation type I and syringomyelia: a systematic review and meta-analysis.

Authors:  Omar F Jbarah; Bahaa I Aburayya; Ayman R Shatnawi; Mohab A Alkhasoneh; Ahmad A Toubasi; Sondos M Alharahsheh; Saleem K Nukho; Asil S Nassar; Mohammad A Jamous
Journal:  Neurosurg Rev       Date:  2022-10-01       Impact factor: 2.800

8.  Acellularization of embryoid bodies via physical disruption methods.

Authors:  Alyssa V Ngangan; Todd C McDevitt
Journal:  Biomaterials       Date:  2008-11-29       Impact factor: 12.479

9.  Histopathological Investigation of the Effectiveness of Collagen Matrix in the Repair of Experimental Spinal Dura Mater Defects.

Authors:  Cagatay Calikoglu; Murteza Cakir; Yusuf Tuzun
Journal:  Eurasian J Med       Date:  2018-12-03

10.  Evaluation of efficacy and biocompatibility of a novel semisynthetic collagen matrix as a dural onlay graft in a large animal model.

Authors:  Axel Neulen; Angelika Gutenberg; Ildikó Takács; György Wéber; Jürgen Wegmann; Walter Schulz-Schaeffer; Alf Giese
Journal:  Acta Neurochir (Wien)       Date:  2011-07-09       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.